Antisense technology in molecular and cellular bioengineering.
Antisense technology is finding increasing application not only in clinical development, but also for cellular engineering. Several types of antisense methods (e.g. antisense oligonucleotides, antisense RNA and small interfering RNA) can be used to inhibit the expression of a target gene. These antisense methods are being used as part of metabolic engineering strategies to downregulate enzymes controlling undesired pathways with regard to product formation. In addition, they are beginning to be utilized to control cell phenotype in tissue engineering constructs. As improved methods for antisense effects that can be externally regulated emerge, these approaches are likely to find increased application in cellular engineering applications.
Department of Chemical and Biochemical Engineering, Rutgers University, 98 Brett Road, Piscataway, NJ 08854, USA.
Li Kim
LK
Lee
Charles M
CM
Roth
D000818:Animals; D002478:Cells, Cultured; D015536:Down-Regulation; D005786:Gene Expression Regulation; D005818:Genetic Engineering; D005822:Genetic Vectors; D008322:Mammals; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000378:metabolism*; D014176:Protein Biosynthesis; D016372:RNA, Antisense / Q000235:genetics / Q000378:metabolism*; D014158:Transcription, Genetic
D016376:Oligonucleotides, Antisense; D016372:RNA, Antisense